According to Shenzhen Salubris Pharmaceuticals's latest financial reports the company's current EPS (TTM) is 0,09712ย โฌ. In 2024 the company made an earnings per share (EPS) of 0,06410ย โฌ an increase over its 2023 EPS that were of 0,06373ย โฌ.